| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |